Pacira BioSciences adopts majority voting standard for uncontested director elections

Pacira BioSciences, Inc.

Board approved Third Amended and Restated Bylaws effective March 12, 2025.
Majority voting applies to uncontested director elections; plurality retained for contested.
No other changes were made to the prior bylaws.
Change is effective immediately upon approval.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Pacira BioSciences, Inc.: Adopted majority voting standard for election of director nominees in uncontested elections, retained plurality for contested elections (effective 2025-03-12).

Change: bylaw amendment
Effective: 2025-03-12

Exact text from the filing

On March 12, 2025, the Board of Directors of Pacira BioSciences, Inc. (the “Company”) approved and adopted the Third Amended and Restated Bylaws of the Company (the “Third Amended and Restated Bylaws”), effective immediately. The Third Amended and Restated Bylaws reflect the adoption of a majority voting standard for the election of director nominees in uncontested director elections, with a plurality vote standard retained for contested director elections.

View on SEC.gov

Browse all governance changes →

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-25-000048

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.